Printer Friendly

Articles from Stem Cell Business News (May 16, 2016)

1-15 out of 15 article(s)
Title Author Type Words
Asterias closes stock offering. 166
Canadian patent for cell selection technology platform. 219
Companies to collaborate via licensing agreement. 170
Company completes development of stem cell liquid suspension. 151
Company grants Japan license for heart regeneration medicine. 253
Company regenerates esophagus in preclinical work with Mayo Clinic. 526
Cynata enters license option agreement with Apceth GmbH. 193
European researchers to use Wafergen Single-Cell Systems. 156
First patient enrolled in phase 2 trial in major depressive disorder. Clinical report 772
Glycopeptide quadruples viability of stem cells in retina. 157
Neuralstem public stock offering. 149
One year Cohort I data from Phase 2 Pathway SCI study. Clinical report 211
StemCells, Inc., reverse stock split. 175
Takara Bio to acquire Wafergen Bio-systems. 185
U.S. patent for treatment of macular degeneration. 103

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters